Advanced Virology is pleased to announce that our chimeric alphaviruses are now available for purchase directly through our website (https://advancedvirology.com/). These virus stocks provide researchers with powerful tools for studying alphavirus pathogenesis, testing vaccines, developing therapeutics and manufacturing diagnostics.
Unlike pseudoviruses, which only mimic select aspects of viral infection, chimeric viruses recapitulate the alphavirus replication cycle and structural protein fidelity to a greater extent. This makes them a more accurate and informative model for studying alphavirus pathogenesis, host interactions, and immune responses. Additionally, chimeric alphaviruses allow the study of BSL-3 and Select Agent alphaviruses such as Venezuelan equine encephalitis virus (VEEV), eastern equine encephalitis virus (EEEV), Western equine encephalitis virus (WEEV) and Chikungunya virus (CHIKV) in BSL-2 non-select agent laboratories.
Alphaviruses are an important group of emerging pathogens with global health significance that have been associated with outbreaks of severe disease. Alphavirus outbreaks continue to pose a threat to human health worldwide. For example, an active Chikungunya virus pandemic is responsible for tens of millions of annual infections worldwide.
By producing these viruses at scale, Advanced Virology is helping ensure that the scientific community has access to novel, high-fidelity reagents needed to accelerate production of vaccines and therapeutics targeting alphaviruses.
We are proud to continue expanding access to high-quality viral reagents and to support researchers working at the forefront of virology.
Explore our catalog and learn more about our custom alphavirus production service at - https://advancedvirology.com/